CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Practice and Policy

ONCOLOGY. Vol. 26 No. 1
COMMENTARY 

Autonomy Versus Paternalism in Latin America

By Karime K. Machado, MD1,2, Paulo M. Hoff, MD, PhD, FACP1,2 | January 17, 2012
1 Instituto do Câncer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil
2 Centro de Oncologia do Hospital Sírio-Libanês, São Paulo, Brazil

In this paper, Dr. Cherny beautifully reviews how to balance the patient's right to be adequately informed about his or her disease with the powerful cultural beliefs held in many parts of the world. This is certainly one of the most difficult tasks in the patient-oncologist relationship. The disclosure of prognostic information to terminally ill patients has emerged within the last 15 years as an important issue, given the greater demands for patient involvement in medical decision making, particularly in the United States.[1] With the evolving emphasis on individual autonomy and freedom, medical paternalism is no longer unquestioningly accepted by society as the principal mode of decision making in health care.[2]

The disclosure of prognosis, even when poor and not completely accurate, is considered ethically justified because it enables patients to exert their autonomy and make treatment decisions that are in alignment with their own goals.[3] Nevertheless, emerging evidence suggests that, too often, realistic conversations about prognosis, the potential benefits and limitations of disease-directed therapy, and the potential role of palliative care occur sporadically and frequently late in the course of the disease.[4-6]

(MORE: Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism)

While a patient's autonomy is held in high regard in the United States, in many cultures and particularly in Latin America, the number of physicians, and families, who believe in paternalism as a form of beneficence is still significant. With the aim of assuring a patient's welfare, physicians may voluntarily withhold information on diagnosis and prognosis, which may in some way interfere with or overrule the patient's preferences.[7]

In this cultural scenario, the illness is commonly considered a shared responsibility of the family. Family members, because of their presumed awareness of the patient's needs, goals, and preferences, play a crucial role in decision making, even when the patient is fully competent, and doctors are often not expected to inform patients that they have a terminal illness.[8-12]

In a small Brazilian study, 38 physicians caring for cancer patients in a tertiary hospital responded to a questionnaire addressing the disclosure of diagnosis and prognosis to the patient. Results showed that 97.4% of the physicians informed their patients of the diagnosis in cases of fatal disease. In cases of adverse prognosis, 63.1% preferred to communicate only with family members, while 31.6% preferred to communicate only with the patient.[7] Paternalism seems to emerge as physicians run out of therapeutic resources. At this point, attitudes become conflicting in relation to the principles of beneficence and autonomy.[7]

An American study showed that most oncologists report disclosing the aspect of a prognosis that involves a cancer's not being curable; however, they tend to avoid using percentages to convey prognosis.[13] Oncologists generally offer information on prognosis to their patients (1) when the patient asks directly about his/her condition, (2) when the physician perceives that the patient has the emotional resources to receive the information, (3) when treatment is not producing the desired results, and (4) when the patient is symptomatic and/or decisions about the treatment must be made. Nevertheless, oncologists' reluctance to disclose the prognosis and thus preserve a patient's hope is held in check by the need to assure that patients have realistic expectations for therapy.[13]

There are two main situations in which not being informed about the diagnosis or prognosis may be ethically justified: (1) when the patient does not wish to know, and (2) when the information delivered may be iatrogenic.[14]

It is worth noting that a patient who desires all the information on his/her diagnosis does not necessarily wish detailed information on his/her prognosis. In fact, most patients feel comfortable with complete information on the diagnosis and partial information on the prognosis.[15]

As for the family, we should consider the afflictions precipitated by being responsible for making decisions. Feelings such as regret and guilt during the course of the patient's disease or after his/her death are not uncommon.[7]

Recent studies in the oncology setting have focused on disclosing [8,16-21] or receiving [22] the news that a cancer has reached its terminal stage, and several clinical guidelines and expert recommendations have been published.[4,23,24]

We believe that an ethical and effective approach is to enhance a patient's autonomy through a medical beneficence that incorporates the patient's values, beliefs, and perspectives, even when these differ from the physician's own beliefs. This is possible through a model of shared decision making in which the patient makes meaningful decisions and final choices empowered by the physician's beneficence.[2,25] For such a model to function effectively, the restoration of trust in the doctor-patient relationship, respect, and the adoption of patient-centered communication are essential.[2,4]

Financial Disclosure: The authors have no significant financial interest or other relationship with the manufacturers of any products or providers of any service mentioned in this article.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

This commentary refers to the following article

Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism





REFERENCES

1. Lynn J, Teno JM, Harrell FEJ. Accurate prognostications of death. Opportunities and challenges for clinicians. West J Med. 1995;163:250-7.

2. Chin JJ. Doctor-patient relationship: from medical paternalism to enhanced autonomy. Singapore Medical J. 2002;43:152-5.

3. Annas GJ. Informed consent, cancer, and truth in prognosis. N Engl J Med. 1994;330:223-5.

4. Peppercorn JM, Smith TJ, Helft PR, et al. American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol. 2011;29;755-60.

5. Keating NL, Landrum MB, Rogers SOJ, et al. Physician factors associated with discussions about end-of-life care. Cancer. 2010;116:998-1006.

6. Stubenrauch JM. Study: Few physicians discussing end-of-life options with advanced-stage patients. Oncology Times. 2010;32:26.

7. Trindade ES, Azambuja LEO, Andrade JP, Garrafa V. (2007). O médico frente ao diagnóstico e prognóstico do câncer avançado. Rev Assoc Med Bras. 2007;53:68-74.

8. Yun YH, Kwon YC, Lee MK, Lee WJ. Experiences and attitudes of patients with terminal cancer and their family caregivers toward the disclosure of terminal illness. J Clin Oncol. 2010;28:1950-7.

9. Leung KK, Liu WJ, Cheng SY, Chiu TY. What do laypersons consider as a good death? Support Care Cancer. 2009;17:691-9.

10. Fallowfield L. Learning how to communicate in cancer settings. Support Care Cancer. 2005;13:349-50.

11. Jiang Y, Liu C, Li JY, et al. Different attitudes of Chinese patients and their families toward truth telling of different stages of cancer. PsychoOncology. 2007;16:928-36.

12. Mystakidou K, Parpa E, Tsilika E, et al. Cancer information disclosure in different cultural contexts. Support Care Cancer. 2004;12:147-54.

13. Gordon EJ, Daugherty CK. 'Hitting you over the head': oncologists' disclosure of prognosis to advanced cancer patients. Bioethics. 2003;17:142-68.

14. Da Silva CH, Cunha RL, Tonaco RB, et al. Not telling the truth in the patient-physician relationship. Bioethics. 2003;17:417-24.

15. Miyata H, Takahashi M, Saito T, et al. Disclosure preferences regarding cancer diagnosis and prognosis: to tell or not to tell? J Med Ethics. 2005;31:447-51.

16. Back AL, Arnold RM. Discussing prognosis: “how much do you want to know?” talking to patients who are prepared for explicit information. J Clin Oncol. 2006;24:4209-13.

17. Bail, WF, Lenzi R, Parker PA, et al. Oncologists' attitudes toward and practices in giving bad news: an exploratory study. J Clin Oncol. 2002;20:2189-96.

18. Chiu TY, Hu WY, Cheng SY, Chen CY. Ethical dilemmas in palliative care: a study in Taiwan. J Med Ethics. 2000;26:353-7.

19. Bruera E, Neumann CM, Mazzocato C, et al. Attitudes and beliefs of palliative care physicians regarding communication with terminally ill cancer patients. Palliat Med. 2000;14:287-98.

20. Blackhall LJ, Murphy ST, Frank G, et al. Ethnicity and attitudes toward patient autonomy. JAMA. 1995;274:820-5.

21. Lorensen M, Davis AJ, Konishi E, Bunch EH. Ethical issues after the disclosure of a terminal illness: Danish and Norwegian hospice nurses' reflections. Nurs Ethics. 2003;10:175-85.

22. Chochinov HM. Dying, dignity, and new horizons in palliative end-of-life care. CA Cancer J Clin. 2006;56:84-103.

23. Morita T, Akechi T, Ikenaga M, et al. Communication about the ending of anticancer treatment and transition to palliative care. Ann Oncol. 2004;15:1551-7.

24. Eggly S, Penner L, Albrecht TL, et al. Discussing bad news in the outpatient oncology clinic: rethinking current communication guidelines. J Clin Oncol. 2006;4:716-9.

25. Charles C, Whelan T, Gafni A. What do we mean by partnership in making decisions about treatment? BMJ. 1999;319:780-2.


 
RELATED CONTENT

How the Sequester Cuts Are Harming Oncology
ONCOLOGY,  May 15, 2013
Are CML Drugs Priced Out of Reach?
May 2, 2013
US Cancer Organizations Say Medicare Cuts Will Negatively Impact Cancer Patients
April 29, 2013
Oncologists Hope Congress Will Exempt Cancer Drugs From Sequester Cuts
April 27, 2013
Groups Issue New Social Media Guidelines for Physicians
April 26, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
Click here to subscribe to our newsletter


CancerNetwork on Facebook
 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Health Care
Evidence on Health Care
Guidelines on Health Care
Patient Education on Health Care
Clinical Trials on Health Care
Practical Articles on Health Care
Research and Reviews on Health Care
All "Health Care" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy